NASDAQ:MGTX - MeiraGTx Stock Price, Forecast & News

MeiraGTx trades on the NASDAQ under the ticker symbol "MGTX."

MeiraGTx Holdings PLC (NASDAQ:MGTX) released its quarterly earnings results on Thursday, November, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.23. The firm had revenue of $3.58 million for the quarter. View MeiraGTx's Earnings History.

MeiraGTx is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for MeiraGTx.

3 Wall Street analysts have issued twelve-month target prices for MeiraGTx's shares. Their forecasts range from $30.00 to $45.00. On average, they anticipate MeiraGTx's stock price to reach $38.33 in the next year. This suggests a possible upside of 88.1% from the stock's current price. View Analyst Price Targets for MeiraGTx.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MeiraGTx in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MeiraGTx.

News coverage about MGTX stock has trended negative this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. MeiraGTx earned a coverage optimism score of -2.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for MeiraGTx.

MeiraGTx saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 841,500 shares, an increase of 11.4% from the December 15th total of 755,700 shares. Based on an average trading volume of 160,700 shares, the days-to-cover ratio is currently 5.2 days. Approximately 3.9% of the company's shares are sold short. View MeiraGTx's Current Options Chain.

Some companies that are related to MeiraGTx include Acceleron Pharma (XLRN), Halozyme Therapeutics (HALO), Audentes Therapeutics (BOLD), Denali Therapeutics (DNLI), Fate Therapeutics (FATE), Regenxbio (RGNX), Cortexyme (CRTX), Editas Medicine (EDIT), SpringWorks Therapeutics (SWTX), Alector (ALEC), Orchard Therapeutics (ORTX), Coherus Biosciences (CHRS), DBV TECHNOLOGIE/S (DBVT), NanoString Technologies (NSTG) and Aerie Pharmaceuticals (AERI).

Based on aggregate information from My MarketBeat watchlists, some companies that other MeiraGTx investors own include AbbVie (ABBV), Kadmon (KDMN), Fate Therapeutics (FATE), Corbus Pharmaceuticals (CRBP), Crispr Therapeutics (CRSP), Exelixis (EXEL), Galmed Pharmaceuticals (GLMD), Intercept Pharmaceuticals (ICPT), Agile Therapeutics (AGRX) and Amarin (AMRN).

(MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager.

MeiraGTx's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Rhenman & Partners Asset Management AB (0.52%). Company insiders that own MeiraGTx stock include Life Sciences Maste Perceptive and Nicole Seligman. View Institutional Ownership Trends for MeiraGTx.

MGTX stock was purchased by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB. Company insiders that have bought MeiraGTx stock in the last two years include Life Sciences Maste Perceptive and Nicole Seligman. View Insider Buying and Selling for MeiraGTx.

Shares of MGTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MGTX stock can currently be purchased for approximately $20.38.

MeiraGTx has a market capitalization of $745.30 million. The company earns $-82,870,000.00 in net income (profit) each year or ($4.39) on an earnings per share basis. MeiraGTx employs 68 workers across the globe.View Additional Information About MeiraGTx.

The official website for MeiraGTx is http://www.meiragtx.com/.

MeiraGTx's mailing address is 450 East 29thStreet 15thFloor, NEW YORK NY, 10016. The company can be reached via phone at 646-860-7985 or via email at [email protected]